White Paper

The Emergence of PROs in Oncology

When a Lethal Disease Becomes Chronic

Read more

Now that oncology patients are surviving longer, survival rate alone is insufficient for novel therapy evaluations. Patient-reported outcomes (PROs) offer an improved option for research outcomes. Check out this comprehensive and actionable guide for integrating PROs into your oncology trial.


Chief Medical and Scientific Officer
Matthew Confeld, PharmD, PhD
Assistant Director, Clinical Research Methodology

Key Takeaways:

  • Regulatory Shifts: How PROs are shaping regulatory agency directives
  • Trial Harmonization: The role of PROs in streamlining global clinical trials
  • Economic Impact: PROs’ influence on payor reimbursement strategies
  • Patient-Centered Approach: Prioritizing the patient’s perspective for better outcomes
  • Best Practices: Strategies for effective PRO integration in clinical trials

Want to learn more about Worldwide Clinical Trials?